Vanesa Gabriela Martinez

Vanesa Gabriela Martinez is an experienced scientific professional with a diverse background in writing, research, and academia. Currently serving as an Expert Scientific Writer at Novartis since November 2019, Vanesa previously held roles including Senior Scientific Writer at nitro and contributed as a media fellow and science writer for The Irish Times since July 2016. Vanesa's research expertise encompasses novel therapies for psoriasis, immunotherapy, and biomarkers for breast cancer resistance, gained through roles at Solvotrin Therapeutics, Trinity College Dublin, and various research institutions in Spain, including IDIBAPS and Institut Catalá d'Oncologia. Vanesa's educational background includes a B.Sc. in Biochemistry from the University of Buenos Aires, complemented by a Ph.D. focused on drug metabolism and chemotherapy resistance.